Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0.25%
1,104.10
+2.73
+0.25%
—1,101.371,103.631,105.311,091.41——
SIXC
Communications
SIXC
Communications
SIXC
-1.50%
604.16
-9.19
-1.50%
—613.35613.35613.35601.49——
SIXE
Energy
SIXE
Energy
SIXE
-0.09%
1,197.81
-1.02
-0.09%
—1,198.831,199.681,199.751,182.41——
SIXI
Industrials
SIXI
Industrials
SIXI
-0.88%
1,740.41
-15.54
-0.88%
—1,755.951,754.061,756.031,734.69——
SIXM
Financials
SIXM
Financials
SIXM
-0.64%
634.44
-4.07
-0.64%
—638.51637.41637.41633.05——
SIXR
Staples
SIXR
Staples
SIXR
-0.31%
840.90
-2.62
-0.31%
—843.52843.35846.40837.93——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.38%
215.13
-0.82
-0.38%
—215.95215.95216.84215.06——
SIXT
Technology
SIXT
Technology
SIXT
+2.86%
3,228.71
+89.80
+2.86%
—3,138.913,189.303,230.853,174.76——
SIXU
Utilities
SIXU
Utilities
SIXU
+0.16%
935.87
+1.50
+0.16%
—934.37934.72938.26927.50——
SIXV
Health care
SIXV
Health care
SIXV
-1.37%
1,457.12
-20.31
-1.37%
—1,477.431,474.121,474.121,451.80——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.83%
2,399.84
+19.65
+0.83%
—2,380.192,389.342,403.042,380.47——
AXGN:NASDAQ
AxoGen, Inc Common Stock
$39.25
+4.92%
(+1.84) 1D
$39.80
+1.40% (+0.55)
After hours
Closed: Apr 24, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for AXGN...
Open
$37.41
High
$39.52
Low
$36.75
Mkt. cap
2.04B
Avg. vol.
1.08M
Volume
1.51M
52-wk high
$39.99
52-wk low
$9.22
EPS
-$0.34
Beta
0.98
Shares outstanding
51.90M
No. of employees
622
News stories
From sources across the web
Profile
Axogen is a developer of surgical solutions, including human tissue grafts, based in Alachua, Florida. Axogen products are designed to remedy peripheral nerve damage. In 2013 the company raised $18 million in its initial public offering. Axogen uses a cell graft technology AVANCE to mimic a human nerve. The company also creates nerve connectors and soft tissue membranes. The company reports sensory and movement recovery in 87 percent of patients with peripheral nerve injuries. Axogen is part of the Sid Martin Biotechnology Incubator. As of 2019, Axogen was the only commercially available allograft approved by the Food and Drug Administration for clinical use. Wikipedia
About AxoGen, Inc Common Stock
CEO-
Employees622
Founded2002
HeadquartersAlachua, Florida, United States
SectorMedical device
Websiteaxogeninc.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
48.56M
56.66M
60.08M
59.90M
Cost of goods sold
13.63M
14.64M
14.09M
15.50M
Cost of revenue
13.63M
14.64M
14.09M
15.50M
Research and development expenses
6.09M
6.85M
7.56M
12.38M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
30.50M
33.49M
36.52M
41.80M
Operating expense
36.59M
40.35M
44.08M
54.18M
Total operating expenses
50.22M
54.99M
58.17M
69.68M
Operating income
-1.66M
1.67M
1.91M
-9.77M
Other non operating income
-195.00K
659.00K
234.00K
-2.02M
EBT including unusual items
-3.83M
579.00K
708.00K
-13.16M
EBT excluding unusual items
-3.83M
579.00K
708.00K
-13.16M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-3.83M
579.00K
708.00K
-13.16M
Net profit margin
-7.90%
1.02%
1.18%
-21.96%
Earnings per share
-0.02
0.12
0.12
0.07
Interest and investment income
272.00K
225.00K
319.00K
352.00K
Interest expense
-2.25M
-1.98M
-1.76M
-1.72M
Net interest expenses
-1.98M
-1.75M
-1.44M
-1.37M
Depreciation and amortization charges
-
-
-
-
EBITDA
134.00K
3.40M
3.64M
-8.04M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer